We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSD
3501
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$3K ﹤0.01%
+200
New +$3.4K
AMJ
3502
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$3K ﹤0.01%
100
-100
-50% -$2.88K
RAD
3503
DELISTED
Rite Aid Corporation
RAD
$3K ﹤0.01%
+81
New +$3.84K
NSL
3504
DELISTED
NUVEEN SENIOR INCM FD
NSL
$3K ﹤0.01%
+500
New +$3.35K
KSPN
3505
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$3K ﹤0.01%
82
+39
+91% +$1.44K
ASPU
3506
DELISTED
ASPEN GROUP, INC.
ASPU
$3K ﹤0.01%
+486
New +$3.04K
FSTX
3507
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$3K ﹤0.01%
+50
New +$2.86K
CAJ
3508
DELISTED
Canon, Inc.
CAJ
$3K ﹤0.01%
100
-244
-71% -$8.4K
PTNR
3509
DELISTED
Partner Communications
PTNR
$3K ﹤0.01%
645
+643
+32,150% +$3.27K
NBEV
3510
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$3K ﹤0.01%
990
+759
+329% +$3.22K
CALA
3511
DELISTED
Calithera Biosciences, Inc
CALA
$3K ﹤0.01%
9
-76
-89% -$24K
CSLT
3512
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$3K ﹤0.01%
634
+179
+39% +$737
JHB
3513
DELISTED
Nuveen Corporate Income November 2021 Target Term Fund
JHB
$3K ﹤0.01%
+300
New +$3.03K
AMRB
3514
DELISTED
American River Bankshares
AMRB
$3K ﹤0.01%
215
+189
+727% +$2.59K
CRHM
3515
DELISTED
CRH Medical Corporation
CRHM
$3K ﹤0.01%
900
-235
-21% -$722
GARS
3516
DELISTED
Garrison Capital Inc.
GARS
$3K ﹤0.01%
338
+203
+150% +$1.68K
CNXM
3517
DELISTED
CNX Midstream Partners LP
CNXM
$3K ﹤0.01%
+200
New +$3.64K
FNJN
3518
DELISTED
Finjan Holdings, Inc.
FNJN
$3K ﹤0.01%
+1,303
New +$3.56K
UWT
3519
DELISTED
VelocityShares3x Long Crude Oil ETNs linked to the S&P GSCI Crude Oil Index ER
UWT
$3K ﹤0.01%
200
-38
-16% -$544
ORG
3520
DELISTED
The Organics ETF
ORG
$3K ﹤0.01%
100
ADRA
3521
DELISTED
Invesco BLDRS Asia 50 ADR Index Fund
ADRA
$3K ﹤0.01%
100
ABDC
3522
DELISTED
Alcentra Capital Corp
ABDC
$3K ﹤0.01%
299
+199
+199% +$2.28K
CMTA
3523
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$3K ﹤0.01%
+200
New +$3.27K
FBR
3524
DELISTED
Fibria Celulose Sa
FBR
$3K ﹤0.01%
200
-300
-60% -$3.56K
ANCB
3525
DELISTED
Anchor Bancorp
ANCB
$3K ﹤0.01%
128
-23
-15% -$579

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.